NDC 0173-0717
ADVAIR HFA
Fluticasone Propionate And Salmeterol Xinafoate
ADVAIR HFA is a Respiratory (inhalation) Aerosol, Metered in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Fluticasone Propionate; Salmeterol Xinafoate.
Product ID | 0173-0717_296f1772-58d7-4742-abc6-4557165605b2 |
NDC | 0173-0717 |
Product Type | Human Prescription Drug |
Proprietary Name | ADVAIR HFA |
Generic Name | Fluticasone Propionate And Salmeterol Xinafoate |
Dosage Form | Aerosol, Metered |
Route of Administration | RESPIRATORY (INHALATION) |
Marketing Start Date | 2009-03-06 |
Marketing Category | NDA / NDA |
Application Number | NDA021254 |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE |
Active Ingredient Strength | 230 ug/1; ug/1 |
Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |